Erratum: FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable? (Inflammopharmacol DOI: 10.1007/s10787-010-0036-6);FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable?

Inflammopharmacology

Volumn 18, Issue 2, 2010, Pages 47-55

  Graham, Garry G ^a,b   Day, Richard O ^a   Graudins, Andis ^c   Mohamudally, Anthoulla ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Acetaminophen; Alcohol; FDA; Hepatotoxicity; Liver disease; Paracetamol

Indexed keywords

COCODAMOL; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIHYDROCODEINE; HYDROCODONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE PLUS PARACETAMOL; PARACETAMOL; DRUG COMBINATION; NARCOTIC ANALGESIC AGENT; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

COMBINATION CHEMOTHERAPY; DRUG OVERDOSE; DRUG USE; FOOD AND DRUG ADMINISTRATION; HUMAN; INCIDENCE; LIVER INJURY; LIVER TOXICITY; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCIENTIST; UNITED STATES; ADVISORY COMMITTEE; DRINKING BEHAVIOR; DRUG COMBINATION; DRUG CONTROL; DRUG LABELING; DRUG PACKAGING; DRUG-INDUCED LIVER INJURY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; LEGISLATION AND JURISPRUDENCE; PAIN;

ACETAMINOPHEN; ADVISORY COMMITTEES; ALCOHOL DRINKING; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG AND NARCOTIC CONTROL; DRUG COMBINATIONS; DRUG LABELING; DRUG PACKAGING; DRUG-INDUCED LIVER INJURY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; NONPRESCRIPTION DRUGS; PAIN; PRESCRIPTION DRUGS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77952243253     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-010-0039-3     Document Type: Erratum

References (30)

1. C Bachert AG Chuchalin R Eisebitt, et al. 2005 Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose ranging study Clin Ther 27 993 1003 10.1016/j.clinthera.2005.06.002 16154478 1:CAS:528:DC%2BD2MXhtVWls7jI (Pubitemid 41262457)
2. DN Bateman 2009 Limiting paracetamol pack size: has it worked in the UK? Clin Toxicol 47 6 536 541 10.1080/15563650903093192
3. GD Benson 1983 Acetaminophen in chronic liver disease Clin Pharmacol Ther 33 95 101 6848304 1:STN:280:DyaL3s%2Fnsl2rsg%3D%3D
4. K Brune B Hinz I Otterness 2009 Aspirin and acetaminophen: should they be available over the counter? Curr Rheumatol Rep 11 36 40 10.1007/s11926-009- 0006-4 19171110 1:CAS:528:DC%2BD1MXitFWmtr8%3D
5. NA Buckley D Gunnel 2007 Does restricting pack size of paracetamol (acetaminophen) reduce suicides? PLoS Med 4 4 e152 10.1371/journal.pmed.0040152 17407389 (Pubitemid 46658758)
6. RC Dart E Bailey 2007 Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy 27 1219 1230 10.1592/phco.27.9.1219 17723075 1:CAS:528:DC%2BD2sXhtVOku77F (Pubitemid 47339119)
7. RC Dart EK Kuffner BH Rumack 2000 Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review Am J Ther 7 123 134 10.1097/00045391-200007020-00009 11319580 1:STN:280: DC%2BD3MzitFKksQ%3D%3D
8. HM den Hertog HB van der Worp HMA van Gemert, et al. 2009 The paracetamol (acetaminophen) in stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial Lancet Neurol 8 434 440 10.1016/S1474- 4422(09)70051-1 1:CAS:528:DC%2BD1MXlsVajsLo%3D
9. P Fabris MD Palma F de Lalla 2001 Idiosyncratic acute hepatitis caused by paracetamol in two patients with melanoma treated with high-dose interferon-α Ann Intern Med 134 345 11182855 1:STN:280: DC%2BD3M7ktl2qsw%3D%3D
10. FDA Background. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ UCM164897.pdf. Accessed 22 January 2010
11. FDA Pack Size. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ UCM168619.pdf. Accessed 22 January 2010
12. FDA Transcript, June 29. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ UCM174697.pdf. Accessed 27 January 2010
13. FDA Transcript, June 30 http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ UCM174699.pdf. Accessed 27 January 2010
14. JA Forrest P Adriaenssens ND Finlayson LF Prescott 1979 Paracetamol metabolism in chronic liver disease Eur J Clin Pharmacol 15 427 431 10.1007/BF00561743 499292 1:CAS:528:DyaL3cXhsFWmtg%3D%3D (Pubitemid 9235912)
15. GK Johnson KG Tolman 1977 Chronic liver disease and acetaminophen Ann Intern Med 87 3 302 304 900674 1:STN:280:DyaE2s3msV2mug%3D%3D
16. SA Khan N Shah R Williams R Jalan 2006 Acute liver failure: a review Clin Liver Dis 10 239 258 10.1016/j.cld.2006.05.010 16971260 (Pubitemid 46110781)
17. EP Krenzelok 2009 The FDA acetaminophen advisory committee meeting-what is the future of acetaminophen in the United States? The perspective of a committee member Clin Toxicol 47 784 789 10.1080/15563650903232345 1:CAS:528:DC%2BD1MXhtFOitbvK
18. AM Larson J Polson RJ Fontana, et al. 2005 Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study Hepatology 42 1364 1372 10.1002/hep.20948 16317692 1:CAS:528:DC%2BD2MXhtlGns7rF (Pubitemid 43260039)
19. WM Lee 2004 Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failure Hepatology 40 6 9 10.1002/hep.20293 15239078 1:CAS:528:DC%2BD2cXmtlSgtL0%3D (Pubitemid 38868915)
20. McIntyre N (1999) The general management of liver disease. In: Bircher J, Benhamou J-P, McIntyre N et al (eds) Oxford Textbook of Clinical Hepatology. Oxford University Press, Oxford, UK, pp 1917-1922
21. HJ McQuay RA Moore 2007 Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies Br J Clin Pharmacol 63 3 271 278 10.1111/j.1365-2125.2006.02723.x 16869819 1:CAS:528:DC%2BD2sXkt1Wkt74%3D
22. Morgan OW, Griffiths C, Majeed A (2007a) Interrupted time-series analysis of regulations to reduce paracetamol (acetaminophen) poisoning. PLoS Med e105
23. O Morgan L Hawkins N Edwards P Dargan 2007 Paracetamol (acetaminophen) pack size restrictions and poisoning severity: time trends in enquiries to a UK poisons centre J Clin Pharm Ther 32 5 449 455 17875110 1:STN:280: DC%2BD2srls1CrtQ%3D%3D
24. P Nourjah SR Ahmad C Karwoski M Willy 2006 Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States Pharmacoepid Drug Saf 15 398 405 10.1002/pds.1191 (Pubitemid 44018697)
25. LF Prescott 2000 Therapeutic misadventure with paracetamol: Fact or fiction Am J Ther 7 99 114 10.1097/00045391-200007020-00007 11319578 1:STN:280:DC%2BD3MzitFKrsA%3D%3D
26. LF Prescott 2000 Paracetamol, alcohol and the liver Br J Clin Pharmacol 49 291 301 10.1046/j.1365-2125.2000.00167.x 10759684 1:CAS:528: DC%2BD3cXjtl2hsLk%3D (Pubitemid 30195271)
27. D Robinson AM Smith GD Johnston, et al. 2000 Severity of overdose after restriction of paracetamol availability: retrospective study Br Med J 321 926 927 10.1136/bmj.321.7266.926 1:STN:280:DC%2BD3M%2FjtVaitA%3D%3D
28. AR Temple JM Lynch J Vena, et al. 2007 Aminotransferase activities in healthy subjects receiving three-day dosing of 4, 6, or 8 grams per day of acetaminophen Clin Toxicol 45 36 44 10.1080/15563650601120792 1:CAS:528:DC%2BD2sXislCksrw%3D
29. Weil K, Hooper L, Afzal Z et al (2007). Paracetamol for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev 3:CD004487
30. P Zapater MC Lasso de la Vega JF Horga, et al. 2004 Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status Aliment Pharmacol Ther 20 29 36 10.1111/j.1365-2036.2004. 02022.x 15225168 1:CAS:528:DC%2BD2cXmsl2lt7c%3D